MADELEINE PHARMACEUTICALS PTY LTD has a total of 20 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ROGERS ARPI, NEURALAB LTD and MEHTA NOZER M.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Syringes | |
#5 | Microorganisms | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Geimer Thomas Robert | 12 |
#2 | Geimer Robert Thomas | 4 |
#3 | Hunt Ben | 4 |
#4 | Bastiras Stan | 4 |
#5 | Upton Richard Neil | 4 |
#6 | Zareie Reza | 4 |
#7 | Guidolin Angelo | 4 |
#8 | Raisheed Muhammad Saif | 2 |
#9 | Raisheed Saif | 2 |
Publication | Filing date | Title |
---|---|---|
AU2015230778A1 | Dosage regimen for therapeutic method | |
US2017020899A1 | ANP fragment adjuvant therapy to standard of care (SOC) diuretic treatment | |
EP2968458A1 | Dosage regimen for therapeutic method | |
AU2014200511A1 | Therapeutic method for treating congestive heart failure | |
EP2839010A1 | Method of producing a recombinant peptide | |
CN103402534A | Therapeutic method for treating congestive heart failure | |
WO2012019237A1 | Therapeutic method for treating congestive heart failure |